Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides

A major challenge for the application of peptide therapeutics is their short half-lifein vivo. Here, the authors design peptide-fatty acid chimeras bearing an engineered linker that promotes albumin binding and allows longer circulation times of therapeutic peptides in animal models.

Saved in:
Bibliographic Details
Main Authors: Alessandro Zorzi, Simon J. Middendorp, Jonas Wilbs, Kaycie Deyle, Christian Heinis
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Q
Online Access:https://doaj.org/article/cb4c3effd8b24083a11b07d420333e2b
Tags: Add Tag
No Tags, Be the first to tag this record!